23.86
price up icon1.13%   0.345
 
loading

Finanzdaten der Veracyte Inc-Aktie (VCYT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
1.38%
96.84
98.20 90.11 90.32 82.42
Operating Expenses
24.09%
101.50
133.71 121.85 98.37 92.92
Benefits Costs and Expenses
23.25%
98.75
128.67 119.88 98.60 90.51
Costs And Expenses
24.09%
101.50
133.71 121.85 98.37 92.92
Operating Income/Loss
86.89%
-4.656
-35.51 -31.74 -8.051 -10.50
Income/Loss From Continuing Operations Before Tax
93.74%
-1.908
-30.47 -29.77 -8.277 -8.091
Income Tax Expense/Benefit
97.98%
-0.044
-2.179 -0.154 0.125 -
Income/Loss From Continuing Operations After Tax
93.41%
-1.864
-28.29 -29.62 -8.402 -8.091
Net Income/Loss
93.41%
-1.864
-28.29 -29.62 -8.402 -8.091
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
47,858%
74.76
0.1559 72.80 72.48 72.18
Diluted Average Shares
47,858%
74.76
0.1559 72.80 72.48 72.18
Basic Earnings Per Share
94.74%
-0.02
-0.38 -0.41 -0.12 -0.11
Diluted Earnings Per Share
94.74%
-0.02
-0.38 -0.41 -0.12 -0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research WAT
$294.55
price up icon 2.28%
$138.91
price down icon 0.72%
diagnostics_research DGX
$177.28
price down icon 0.78%
diagnostics_research LH
$254.44
price up icon 0.86%
diagnostics_research MTD
$1,254.70
price up icon 2.93%
diagnostics_research IQV
$190.44
price up icon 1.64%
Kapitalisierung:     |  Volumen (24h):